Personal information

Activities

Collapse all

Employment (1)

Heidelberg University Hospital: Heidelberg, DE

(Radiation oncology)
Employment
Source: Self-asserted source
Jonas Ristau

Works (3)

Stereotactic ultrahypofractionated MR-guided radiotherapy for localized prostate cancer – Acute toxicity and patient-reported outcomes in the prospective, multicenter SMILE phase II trial

Clinical and Translational Radiation Oncology
2024-05 | Journal article
DOI: 10.1016/j.ctro.2024.100771
Contributors: C.A. Fink; J. Ristau; C. Buchele; S. Klüter; J. Liermann; P. Hoegen-Saßmannshausen; E. Sandrini; A. Lentz-Hommertgen; L. Baumann; N. Andratschke et al.
Source: check_circle
Crossref

Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk

Clinical and Translational Radiation Oncology
2023-03 | Journal article
DOI: 10.1016/j.ctro.2022.100567
Contributors: Philipp Hoegen; Efthimios Katsigiannopulos; Carolin Buchele; Sebastian Regnery; Fabian Weykamp; Elisabetta Sandrini; Jonas Ristau; Jakob Liermann; Eva Meixner; Tobias Forster et al.
Source: check_circle
Crossref

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases

Cancers
2022-12-08 | Journal article
DOI: 10.3390/cancers14246041
Contributors: Fabian Weykamp; Efthimios Katsigiannopulos; Lars Piskorski; Sebastian Regnery; Philipp Hoegen; Jonas Ristau; C. Katharina Renkamp; Jakob Liermann; Tobias Forster; Kristin Lang et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎
How many people are using ORCID?